大博医疗股价上涨8.44% 中报净利润预增超66%

Core Viewpoint - Dabo Medical's stock price increased by 4.15 yuan to 53.30 yuan as of August 5, 2025, indicating positive market sentiment and performance expectations for the company [1]. Company Summary - Dabo Medical specializes in the research, production, and sales of high-value medical consumables, including orthopedic trauma, spinal, and joint implant materials, as well as surgical instruments [1]. - The company is located in Xiamen, Fujian Province, and operates within the medical device industry [1]. Financial Performance - The company expects a net profit attributable to shareholders of 230 million to 250 million yuan for the first half of 2025, representing a year-on-year growth of 66.37% to 80.84% [1]. - This anticipated performance has led to the emergence of the "2025 mid-term report pre-increase" concept for the company [1]. Market Activity - On August 5, 2025, Dabo Medical experienced a net outflow of main funds amounting to 15.49 million yuan, which is 0.1% of its circulating market value [1]. - Over the past five trading days, the cumulative net inflow of main funds reached 61.78 million yuan, accounting for 0.4% of the circulating market value [1].